As per MRFR analysis, the South Korea Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 35.2 (USD Million) in 2023. The South Korea Extracorporeal Membrane Oxygenation Machine Market Industry is expected to grow from 37.2(USD Million) in 2024 to 70 (USD Million) by 2035. The South Korea Extracorporeal Membrane Oxygenation Machine Market CAGR (growth rate) is expected to be around 5.916% during the forecast period (2025 - 2035).
The South Korea Extracorporeal Membrane Oxygenation (ECMO) Machine Market has been experiencing notable growth driven by several key market drivers. The increasing prevalence of respiratory diseases and cardiac conditions in the country is a significant factor fueling the demand for ECMO machines. Moreover, the government's strong emphasis on healthcare infrastructure and advancements in medical technology enable better access to high-quality ECMO services. South Korea's commitment to enhancing patient care and reducing mortality rates in critical situations has fostered innovations in ECMO technology, expanding its application beyond traditional use in newborns to adult and pediatric patients as well.
The South Korean ECMO machine market offers a plethora of opportunities for exploration. The opportunity for manufacturers to enhance their product offerings and collaborate with institutions is presented by the increasing awareness among healthcare providers of the benefits and capabilities of ECMO technology. Additionally, the demand for portable ECMO systems is increasing, which may result in improvements in product development and customisation to better adapt to the requirements of a variety of healthcare facilities, particularly in emergency situations. In South Korea, there has been a recent trend towards the development of more comprehensive training and education programs for healthcare professionals who specialise in ECMO.
This emphasis on operational efficiency and the promotion of best practices in ECMO application can result in enhanced patient outcomes. Furthermore, the pandemic has underscored the necessity of robust respiratory support systems, which has prompted additional investment in ECMO technologies. In general, the South Korean ECMO machine market is poised for ongoing development, as a result of technological advancements and a commitment to enhancing healthcare delivery in the nation.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Rising Incidence of Respiratory Diseases
The South Korea Extracorporeal Membrane Oxygenation Machine Market is primarily driven by the increasing incidence of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and pneumonia. According to the Korean Ministry of Health and Welfare, the prevalence of COPD in South Korea has increased by approximately 8% over the last decade, affecting over 3 million individuals. This escalating patient population necessitates advanced therapeutic interventions like Extracorporeal Membrane Oxygenation (ECMO), highlighting the essential role of ECMO machines in critical care settings.
Major medical institutions like Seoul National University Hospital and Samsung Medical Center are pivotal in implementing ECMO technologies, which supports the market growth in South Korea.
Advancements in Healthcare Infrastructure
South Korea's commitment to enhancing its healthcare infrastructure is a significant driver for the Extracorporeal Membrane Oxygenation Machine Market. The government has made substantial investments, exceeding 10% of its national budget, into modernizing healthcare facilities and integrating advanced medical technologies. Publications from the Korean Ministry of Health indicate that around 30% of hospitals are now equipped with cutting-edge ECMO machines, a considerable increase compared to previous years.
This dedication to improving healthcare services ensures better patient outcomes and increases the demand for ECMO machines, positioning South Korea as a leader in critical care.
Surge in Cardiac Surgeries
The rise in the number of cardiac surgeries performed in South Korea directly influences the growth of the Extracorporeal Membrane Oxygenation Machine Market. Data from the Korean Cardiac Society states that cardiac surgery procedures have increased by approximately 5% annually, reaching close to 200,000 operations in recent years. With ECMO being an essential support system during high-risk cardiac surgeries, such as heart transplants and complex valve repairs, hospitals are increasingly incorporating these machines.
Renowned institutions like Asan Medical Center lead the way in utilizing ECMO during complex cardiac procedures, further driving demand in the South Korean healthcare landscape.
Increase in Research and Development Initiatives
An increase in Research and Development (R&D) initiatives related to ECMO technology is bolstering the South Korea Extracorporeal Membrane Oxygenation Machine Market. The Korean government, alongside various academic institutions such as Yonsei University and POSTECH, has amplified efforts to innovate and enhance ECMO systems. Recent reports highlight that R&D spending in medical technologies has surged by over 15% in the past five years, contributing to several advancements in ECMO machine performance and efficacy.
This vital focus on innovation not only boosts the quality of care but also stimulates the growth potential of the ECMO market in South Korea.
The South Korea Extracorporeal Membrane Oxygenation Machine Market is experiencing substantial growth, driven by advancements in medical technology and an increasing demand for innovative solutions in critical care environments. In the Application segment, the market is primarily categorized into Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass. Each of these categories plays a vital role in the healthcare landscape of South Korea, addressing unique patient needs and contributing to improved clinical outcomes.
Cardiac Support has garnered attention due to its capability of providing life-sustaining circulation during severe cardiac dysfunction. This application area has proven to be indispensable in treating patients with severe heart failure, often acting as a bridge to recovery or a long-term solution for patients awaiting transplant. The growing prevalence of cardiovascular diseases in South Korea emphasizes the significance of this application, propelling innovations and enhancements in ECMO technologies designed to improve patient care.
Respiratory Support also commands a notable position within the market, particularly in the context of rising respiratory infections and conditions, including those exacerbated by pollution and COVID-19. As respiratory distress becomes more common, the use of ECMO in this segment is becoming essential for managing critically ill patients who require prolonged ventilation support. The ability of this technology to provide oxygenation and carbon dioxide removal underlines its importance in managing respiratory failure, especially in an environment where healthcare demand is surpassing resource availability.
Meanwhile, Cardiopulmonary Bypass remains integral to many surgical procedures, especially in cardiac surgery where maintaining blood flow and oxygenation during operations is critical. This application has been a longstanding standard in cardiac surgeries, reflecting the technology's reliability and effectiveness. The ongoing performance improvements and procedural methodologies in conjunction with ECMO systems showcase the vital interconnection between surgical advancements and ECMO technologies in enhancing patient outcomes.
Overall, the South Korea Extracorporeal Membrane Oxygenation Machine Market's Application segment reflects a dynamic healthcare environment focused on improving the critical care capabilities available to patients, driven by local healthcare initiatives and the latest medical research. This segment not only highlights the immediate healthcare needs but also indicates larger trends towards specialization and adaptation in medical interventions, setting the stage for further development in the industry.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The South Korea Extracorporeal Membrane Oxygenation Machine Market, segmented by End User, showcases a diverse landscape with significant contributions from various settings including hospitals, ambulatory surgical centers, and home care environments. Hospitals are pivotal in this market, serving as primary care providers equipped with advanced technologies and skilled professionals for critical care procedures. The increasing number of patients with respiratory and cardiac issues further elevates the demand for these machines in healthcare facilities.
Meanwhile, ambulatory surgical centers represent a growing sector, emphasizing efficiency and targeted care for less severe cases, leveraging these machines in procedural settings. Home care settings are also emerging significantly, reflecting a trend towards at-home health management, allowing patients to receive specialized care in the comfort of their own homes. This evolution is backed by the aging population in South Korea and its focus on reducing hospital stay durations, making home care a viable option for many. Overall, this segmentation underlines a strategic importance as it addresses the needs of various patient demographics while bolstering market growth through innovative applications and tailored care solutions.
The South Korea Extracorporeal Membrane Oxygenation Machine Market is marked by distinct product types, prominently featuring Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO. Each of these types plays a critical role in the management of severe respiratory and cardiac conditions. Venoarterial ECMO is extensively utilized for patients with cardiac failure, providing life support by aiding in both oxygenation and hemodynamic support, hence, it holds a majority share in the ECMO market. Venovenous ECMO primarily serves patients experiencing severe respiratory failure, allowing for oxygenation of blood while maintaining cardiac function; this segment is gaining traction due to the increased occurrence of respiratory diseases in South Korea.
Arteriovenous ECMO, while less common, is significant for specific clinical uses, particularly in patients requiring blood purification processes. The growth of the South Korea Extracorporeal Membrane Oxygenation Machine Market is driven by technological advancements and increasing healthcare awareness, alongside a rising aging population, which in turn influences demand across these critical product types. Moreover, these segments would require constant support in terms of Research and Development for innovations and regulatory compliance to ensure optimal patient outcomes.
The Component segment of the South Korea Extracorporeal Membrane Oxygenation Machine Market is pivotal in advancing cardiac and respiratory support therapies. Particularly, the Membrane Oxygenator plays a crucial role by facilitating the exchange of gases, ensuring that patients receive adequate oxygenation during critical care. Blood Pumps, essential for maintaining circulatory flow, greatly enhance device performance and patient outcomes, making them indispensable in acute situations. Additionally, Heat Exchangers contribute significantly to controlling patient temperatures, thereby reducing complications during procedures.
As healthcare providers increasingly focus on precision and efficiency, these components are gaining prominence in the South Korean healthcare landscape. The growing prevalence of cardiovascular diseases and advancements in medical technologies are also driving the demand within this segment. These trends in the South Korea Extracorporeal Membrane Oxygenation Machine Market underscore an evolving landscape emphasizing quality, innovation, and patient-centric care.
South Korea Extracorporeal Membrane Oxygenation Machine Market Key Players and Competitive Insights:
The South Korea Extracorporeal Membrane Oxygenation Machine Market is characterized by significant advancements in medical technology and a growing demand for high-quality healthcare solutions. As hospitals and healthcare facilities increasingly adopt ECMO systems for critical care, the competitive landscape has intensified, with various entities vying for market share. Innovation and technological sophistication play a pivotal role in differentiation among market players, with companies focusing on enhancing the efficiency, reliability, and ease of use of their ECMO machines.
Factors such as regulatory approvals, product certifications, and the ability to provide comprehensive support and training further influence competitive dynamics, consequently positioning certain manufacturers as leaders in this domain. The market also reflects broader trends in the healthcare sector, such as the rising prevalence of respiratory diseases and cardiac conditions, thereby driving the demand for sophisticated respiratory support technology.
Dahua Technology has established a noteworthy position within the South Korea Extracorporeal Membrane Oxygenation Machine Market. The company's commitment to cutting-edge technology and innovative design strongly enhances its competitiveness in the region. By focusing on the development of high-performance ECMO machines, Dahua Technology offers products that are tailored to meet the specific needs of healthcare providers. Their strength lies in their robust research and development capabilities, which foster the introduction of advanced features that enhance patient care. Additionally, Dahua Technology has built a solid network of partnerships with hospitals and medical institutions, facilitating the integration of their solutions into clinical practice. This collaborative approach not only bolsters their market presence but also reinforces their reputation as a trusted partner in the medical community.
Schiller's presence in the South Korea Extracorporeal Membrane Oxygenation Machine Market is marked by a diverse portfolio of products that cater to critical care applications. Known for its reliable and efficient medical devices, Schiller remains a key player in this industry, renowned for introducing innovative ECMO solutions that ensure optimum patient outcomes. The company emphasizes its commitment to quality and precision, which resonates with the rigorous standards upheld in South Korea's healthcare system. Their market presence is bolstered by strategic initiatives, including collaborations and potential mergers, aimed at expanding their reach and enhancing service capabilities.
Schiller's strengths lie in its advanced technological offerings and comprehensive training programs for healthcare providers, ensuring that their ECMO machines are utilized effectively in patient care. The company's ability to adapt to the evolving demands of the market and maintain high standards of innovation positions it favorably within the competitive landscape of the South Korean ECMO machine market.
Key Companies in the South Korea Extracorporeal Membrane Oxygenation Machine Market Include:
South Korea Extracorporeal Membrane Oxygenation Machine Market Industry Developments
The South Korea Extracorporeal Membrane Oxygenation Machine Market has witnessed significant developments recently. Notable companies such as Medtronic and Fresenius Medical Care are enhancing their product offerings with innovative features to meet the increasing demand for advanced healthcare solutions. The market has shown promising growth, valued at approximately USD 80 million in early 2023, reflecting an increase driven by rising cardiovascular diseases and an aging population. In August 2023, Medtronic announced a strategic collaboration with a local healthcare provider to improve its distribution capabilities in South Korea, leveraging local expertise to expand market penetration.
Additionally, in September 2023, Dahua Technology launched a new digital solution aimed at integrating ECMO machines into hospital systems, enhancing patient data management. Key players, including Asahi Kasei and Terumo, are also investing in Research and Development to advance ECMO technology. In recent years, the market has experienced robust growth, with notable advancements reported in late 2022, highlighting the critical role of ECMO in treating severe respiratory and cardiac conditions. The South Korean government continues to support the healthcare sector, promoting investments and innovations in advanced medical technologies, including ECMO systems, to improve patient outcomes nationwide.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 35.2(USD Million) |
| MARKET SIZE 2024 | 37.2(USD Million) |
| MARKET SIZE 2035 | 70.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.916% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Dahua Technology, Schiller, Medtronic, Jiangsu Yuyue Medical Equipment, Boston Scientific, Fresenius Medical Care, Huaan Medical, Asahi Kasei, Terumo, MediServe, Nipro, Livanova, Sorin Group, Getinge, Abbott Laboratories |
| SEGMENTS COVERED | Application, End User, Product Type, Component |
| KEY MARKET OPPORTUNITIES | Increasing prevalence of respiratory diseases, Growing elderly population requiring ECMO, Advances in ECMO technology and devices, Expanding healthcare infrastructure investments, Rising demand for organ transplant support |
| KEY MARKET DYNAMICS | growing cardiovascular disease prevalence, technological advancements in ECMO, increasing geriatric population, enhanced healthcare infrastructure, government healthcare initiatives |
| COUNTRIES COVERED | South Korea |
Frequently Asked Questions (FAQ) :
The South Korea Extracorporeal Membrane Oxygenation Machine Market is expected to be valued at 37.2 million USD in 2024.
By 2035, the market is projected to reach a value of 70.0 million USD.
The market is anticipated to grow at a CAGR of 5.916% from 2025 to 2035.
The Cardiac Support application is expected to dominate with a market value of 15.0 million USD in 2024.
The Respiratory Support application is valued at 12.0 million USD in 2024.
By 2035, the Cardiopulmonary Bypass application is projected to be valued at 15.0 million USD.
Major players include Medtronic, Fresenius Medical Care, and Getinge among others.
The market value for Cardiac Support is expected to reach 30.0 million USD by 2035.
The growth opportunities are driven by advancements in medical technology and increasing demand for cardiac and respiratory support.
The market is influenced by global healthcare advancements and rising investment in medical equipment technology.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
